Alnylam Pharmaceuticals Inc

Official name: 
Alnylam Pharmaceuticals Incorporated
Registration country: 
United States
ISIC Code: 
2100
Overview: 
Alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. With RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.